Japan, Oct. 30 -- VIELA BIO INC has got intellectual property rights for 'ANTIBODIES TO FELINE MCDONOUGH SARCOMA (FMS)-LIKE TYROSINE KINASE 3 RECEPTOR LIGAND (FLT3L) AND USES THEREOF FOR TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES.' Other related details are as follows:

Application Number: JP,2023-118763

Category (FI): C12Q1/02,A61K39/395@N,A61K39/395@V,A61P13/12,A61P17/06,A61P19/02,A61P21/00,A61P29/00,A61P37/02,A61P37/06,A61P9/10,101,C07K16/24,C12N1/15,C12N1/19,C12N1/21,C12N15/13,C12N15/63@Z,C12N5/10,C12N5/16,C12N9/12,C12P21/08,G01N33/68

Stage: Grant (IP right document published.)

Filing Date: July 21, 2023

Publication Date: Oct. 3, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Cu...